Il y a eu 50 transactions d'initiés récentes enregistrées pour Century Therapeutics, Inc. (IPSC), dont 22 achats et 27 ventes. Le total des achats d'initiés s'élève à $3.99M et le total des ventes d'initiés à $300.89K.
Les initiés notables ayant une activité récente comprennent Cowan Chad, Carr Douglas, Russotti Gregory. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — IPSC
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-01 |
Cowan Chad |
Chief Scientific Officer |
Retenue Fiscale RSU |
1,365 |
$2.19 |
$2.99K |
1,175,680 |
| 2026-03-12 |
Carr Douglas |
SVP Finance & Operations |
Vente Informative |
7,043 |
$2.55 |
$17.95K |
507,261 |
| 2026-03-12 |
Russotti Gregory |
See Remarks |
Vente Informative |
10,076 |
$2.55 |
$25.68K |
515,427 |
| 2026-03-11 |
Pfeiffenberger Brent |
President and CEO |
Retenue Fiscale RSU |
55,397 |
$2.73 |
$151.23K |
3,710,958 |
| 2026-03-11 |
Cowan Chad |
Chief Scientific Officer |
Retenue Fiscale RSU |
1,431 |
$2.73 |
$3.91K |
1,177,045 |
| 2026-03-09 |
Russotti Gregory |
See Remarks |
Vente Informative |
479 |
$2.54 |
$1.21K |
525,503 |
| 2026-03-06 |
Pfeiffenberger Brent |
President and CEO |
Retenue Fiscale RSU |
463 |
$2.56 |
$1.19K |
3,766,355 |
| 2026-02-13 |
Pfeiffenberger Brent |
President and CEO |
Retenue Fiscale RSU |
31,172 |
$1.75 |
$54.55K |
3,766,818 |
| 2026-02-03 |
Carr Douglas |
SVP Finance & Operations |
Vente Informative |
323 |
$1.82 |
$588.51 |
514,551 |
| 2026-02-02 |
Carr Douglas |
SVP Finance & Operations |
Attribution de RSU |
225,000 |
$1.84 |
$414K |
225,000 |
| 2026-02-02 |
Russotti Gregory |
See Remarks |
Attribution de RSU |
265,000 |
$1.84 |
$487.6K |
265,000 |
| 2026-02-02 |
Pfeiffenberger Brent |
President and CEO |
Attribution de RSU |
945,000 |
$1.84 |
$1.74M |
945,000 |
| 2026-02-02 |
Cowan Chad |
Chief Scientific Officer |
Attribution de RSU |
265,000 |
$1.84 |
$487.6K |
265,000 |
| 2026-01-02 |
Cowan Chad |
Chief Scientific Officer |
Retenue Fiscale RSU |
1,611 |
$1.00 |
$1.6K |
1,043,476 |
| 2025-12-22 |
Cowan Chad |
Chief Scientific Officer |
Achat Informatif |
58,060 |
$0.85 |
$49.25K |
1,045,087 |
| 2025-12-12 |
Pfeiffenberger Brent |
President and CEO |
Achat Informatif |
52,000 |
$0.58 |
$30.35K |
3,322,990 |
| 2025-12-10 |
Pfeiffenberger Brent |
President and CEO |
Retenue Fiscale RSU |
463 |
$0.53 |
$243.54 |
3,270,990 |
| 2025-12-09 |
Lee Han Myung |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-12-09 |
Lee Han Myung |
Director |
Attribution de RSU |
88,000 |
$0.59 |
$52.1K |
88,000 |
| 2025-12-08 |
Carr Douglas |
SVP Finance & Operations |
Vente Informative |
257 |
$0.53 |
$136.72 |
404,874 |
| 2025-12-08 |
Russotti Gregory |
See Remarks |
Vente Informative |
526 |
$0.53 |
$279.83 |
390,982 |
| 2025-11-20 |
Cowan Chad |
Chief Scientific Officer |
Vente Informative |
5,462 |
$0.50 |
$2.74K |
987,027 |
| 2025-11-19 |
Pfeiffenberger Brent |
President and CEO |
Achat Informatif |
35,000 |
$0.50 |
$17.33K |
3,271,453 |
| 2025-11-17 |
Pfeiffenberger Brent |
President and CEO |
Vente Informative |
32,456 |
$0.45 |
$14.74K |
3,236,453 |
| 2025-11-03 |
Carr Douglas |
SVP Finance & Operations |
Vente Informative |
292 |
$0.59 |
$171.11 |
405,131 |
| 2025-09-18 |
Cowan Chad |
Chief Scientific Officer |
Attribution de RSU |
762,543 |
- |
- |
992,489 |
| 2025-09-08 |
Carr Douglas |
SVP Finance & Operations |
Vente Informative |
263 |
$0.50 |
$131.50 |
405,423 |
| 2025-09-08 |
Russotti Gregory |
See Remarks |
Vente Informative |
539 |
$0.50 |
$269.50 |
391,508 |
| 2025-09-08 |
Pfeiffenberger Brent |
President and CEO |
Vente Informative |
488 |
$0.50 |
$244.00 |
3,268,909 |
| 2025-08-14 |
Pfeiffenberger Brent |
President and CEO |
Attribution de RSU |
1,587,614 |
- |
- |
3,269,397 |
| 2025-08-04 |
Carr Douglas |
SVP Finance & Operations |
Vente Informative |
296 |
$0.53 |
$158.06 |
405,686 |
| 2025-06-12 |
Jimenez Joseph |
Director |
Attribution de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Butitta Cynthia M |
Director |
Attribution de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Walbert Timothy P |
Director |
Attribution de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Quimi Daphne |
Director |
Attribution de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Blackwell Kimberly |
Director |
Attribution de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Carlo Rizzuto |
Director |
Attribution de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Riva Alessandro |
Director |
Attribution de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-09 |
Carr Douglas |
SVP Finance & Operations |
Vente Informative |
4,904 |
$0.62 |
$3.05K |
405,982 |
| 2025-06-09 |
Russotti Gregory |
See Remarks |
Vente Informative |
526 |
$0.62 |
$327.17 |
392,047 |
| 2025-06-09 |
Farid Adrienne |
Chief Operations Officer |
Vente Informative |
552 |
$0.62 |
$343.34 |
250,141 |
| 2025-06-09 |
Pfeiffenberger Brent |
President and CEO |
Vente Informative |
475 |
$0.62 |
$295.45 |
1,681,783 |
| 2025-05-16 |
Pfeiffenberger Brent |
President and CEO |
Vente Informative |
29,552 |
$0.55 |
$16.14K |
1,682,258 |
| 2025-05-05 |
Carr Douglas |
SVP Finance & Operations |
Vente Informative |
295 |
$0.55 |
$162.25 |
410,886 |
| 2025-05-05 |
Farid Adrienne |
Chief Operations Officer |
Vente Informative |
1,024 |
$0.55 |
$563.20 |
250,693 |
| 2025-03-11 |
Carr Douglas |
SVP Finance & Operations |
Attribution de RSU |
95,625 |
$0.60 |
$57.47K |
95,625 |
| 2025-03-11 |
Russotti Gregory |
See Remarks |
Attribution de RSU |
120,000 |
$0.60 |
$72.12K |
120,000 |
| 2025-03-11 |
Farid Adrienne |
Chief Operations Officer |
Attribution de RSU |
120,000 |
$0.60 |
$72.12K |
120,000 |
| 2025-03-11 |
Conn Morgan |
Chief Finanical Officer |
Attribution de RSU |
19,500 |
$0.60 |
$11.72K |
19,500 |
| 2025-03-11 |
Pfeiffenberger Brent |
President and CEO |
Attribution de RSU |
521,500 |
$0.60 |
$313.42K |
521,500 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
